CTNPT 050: Perception of menopausal hormone therapy among women living with HIV

Study Approach

The study will consist of two parts: i) a qualitative assessment of menopause, menopausal symptoms and treatments; and ii) a larger survey assessment of menopause treatments in women living with and without HIV. For the qualitative assessment, participants will be recruited from British Columbia and Ontario. In British Columbia, recruitment will be through the ongoing BC CARMA-CHIWOS Collaboration (BCC3; CTN 335), a study of healthy aging for women living with HIV that recruits from several sites across the province (Vancouver, Prince George, Victoria, Kelowna). In Ontario, recruitment will be through word of mouth and postings in community centers and HIV clinics in Toronto, Ottawa, and Hamilton. In both provinces, focus groups will be conducted by a study team member and community research associate to identify beliefs, attitudes, and preferences towards hormone therapy. A total of six focus groups will be held with five to six participants per group (~30 total participants). This content will be used to draft and finalize a questionnaire that will be administered to 100 women living with HIV, as well as 100 women not living with HIV. This survey will gather information about womens’ perspectives on hormone therapy and understand how they differ between those living with and without HIV.

Vel et tristique magna quam. Amet vel ac non nunc. Ut enim, amet, vestibulum lorem id enim elit, feugiat facilisis. Posuere erat eu ut consequat nunc. Amet egestas donec eros amet ultricies mi aliquam. Non eget semper mollis enim scelerisque malesuada eget. Porttitor pretium nibh nibh vitae convallis. Diam at et consequat viverra felis, purus. Et odio mollis facilisis proin cras ullamcorper integer tortor. Sit tincidunt viverra turpis aliquet enim. Quam neque nibh rhoncus tortor. Neque sed dolor aliquet sagittis, malesuada.